PR

Prelude Therapeutics IncNASDAQ PRLD Stock Report

Last reporting period 30 Sep, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.121

Micro

Exchange

XNAS - Nasdaq

View Section: Price ratios

Prelude Statements

PR

Data from Prelude`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Sep, 2024

Next reporting period:

29 Dec, 2024

Report frequency:

Quarterly

Earnings release date:

06 Nov, 2024

Expected release date:

12 Aug, 2024

Prelude Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-09-30
%

3

100

0

0

29.457

981.9

7.919

264

37.376

0.6 %

1245.9

-34.376

7.5 %

-1145.9

0

2.105

70.2

-32.271

7.1 %

-1075.7

0

-32.271

7.1 %

-1075.7

-0.425

75.856

2024-06-30
%

100

0

0

29.509

0

7.655

0

37.164

8.2 %

0

-37.164

-8.2 %

0

0

2.424

0

-34.74

-10.5 %

0

0

-34.74

-10.5 %

0

-0.459

75.762

2024-03-31
%

100

0

0

27.409

0

6.934

0

34.343

-8.1 %

0

-34.343

8.1 %

0

0

2.912

0

-31.431

5 %

0

0

-31.431

5 %

0

-0.415

75.736

2023-12-31
%

100

0

0

30.332

0

7.047

0

37.379

11.9 %

0

-37.379

-11.9 %

0

0

4.304

0

-33.075

-8.1 %

0

0

-33.075

-8.1 %

0

-0.475

69.592

2023-09-30
%

100

0

0

26.26

0

7.12

0

33.39

3.1 %

0

-33.39

-3.1 %

0

0

2.78

0

-30.61

-0.6 %

0

0

-30.61

-0.6 %

0

-0.45

67.64

2023-06-30
%

100

0

0

24.97

0

7.43

0

32.4

11.3 %

0

-32.4

-11.3 %

0

0

1.97

0

-30.43

-9.8 %

0

0

-30.43

-9.8 %

0

-0.54

56.24

2023-03-31
%

100

0

0

21.83

0

7.28

0

29.12

-12.8 %

0

-29.12

12.8 %

0

0

1.4

0

-27.72

3.2 %

0

0

-27.72

3.2 %

0

-0.58

47.74

2022-12-31
%

100

0

0

25.87

0

7.52

0

33.39

9.8 %

0

-33.39

-9.8 %

0

0

4.74

0

-28.64

4.4 %

0

0

-28.64

4.4 %

0

-0.6

47.69

2022-09-30
%

100

0

0

22.89

0

7.52

0

30.41

3.2 %

0

-30.41

-3.2 %

0

0

0.45

0

-29.96

-9.5 %

0

0

-29.96

-9.5 %

0

-0.63

47.45

2022-06-30
%

100

0

0

21.31

0

8.15

0

29.46

-2.7 %

0

-29.46

2.7 %

0

0

2.09

0

-27.37

7.1 %

0

0

-27.37

7.1 %

0

-0.58

47.28

2022-03-31
%

100

0

0

22.82

0

7.47

0

30.29

-8.2 %

0

-30.29

8.2 %

0

0

0.82

0

-29.47

10.3 %

0

0

-29.47

10.3 %

0

-0.63

47.07

2021-12-31
%

100

0

0

25.18

0

7.83

0

33.01

7 %

0

-33.01

-7 %

0

0

0.17

0

-32.84

-7 %

0

0

-32.84

-7 %

0

-0.7

46.68

2021-09-30
%

100

0

0

22.72

0

8.12

0

30.84

10.5 %

0

-30.84

-10.5 %

0

0

0.15

0

-30.69

-14.2 %

0

0

-30.69

-14.2 %

0

-0.66

46.33

2021-06-30
%

100

0

0

22.41

0

5.51

0

27.92

27.1 %

0

-27.92

-27.1 %

0

0

1.06

0

-26.87

-26.2 %

0

0

-26.87

-26.2 %

0

-0.58

46.06

2021-03-31
%

100

0

0

16.47

0

5.5

0

21.97

13 %

0

-21.97

-13 %

0

0

0.67

0

-21.3

-10.6 %

0

0

-21.3

-10.6 %

0

-0.47

45.12

2020-12-31
%

100

0

0

14.57

0

4.87

0

19.45

7.2 %

0

-19.45

-7.2 %

0

0

0.2

0

-19.25

-14.9 %

0

0

-19.25

-14.9 %

0

-0.52

37.1

2020-09-30
%

100

0

0

15.29

0

2.85

0

18.14

-14.3 %

0

-18.14

14.3 %

0

0

1.38

0

-16.76

19.9 %

0

0

-16.76

19.9 %

0

-3.92

4.27

2020-06-30
%

100

0

0

18.312

0

2.861

0

21.173

109.6 %

0

-21.173

-109.6 %

0

0

0.254

0

-20.919

-108.4 %

0

0

-20.919

-108.4 %

0

-4.899

4.27

2019-12-31
%

100

0

0

8.85

0

1.25

0

10.1

0

-10.1

0

0

0.06

0

-10.04

0

0

-10.04

0

-2.35

4.27

View Section: Balance Sheet